Bausch Health Companies Inc. Goodwill, Other Increase (Decrease)
Bausch Health Companies Inc. (BHC) reported Goodwill, Other Increase (Decrease) of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2024-02-22.
Discontinued › Notes › Intangible Assets › Goodwill and Other
us-gaap:GoodwillOtherIncreaseDecrease · last filed 2024-02-22
- Bausch Health Companies Inc. goodwill, other increase (decrease) for the quarter ending 2022-12-31 was $0.00.
- Bausch Health Companies Inc. goodwill, other increase (decrease) for the quarter ending 2022-09-30 was $0.00.
- Bausch Health Companies Inc. goodwill, other increase (decrease) for the quarter ending 2022-06-30 was $0.00.
- Bausch Health Companies Inc. goodwill, other increase (decrease) for the quarter ending 2022-03-31 was $0.00.
- Bausch Health Companies Inc. goodwill, other increase (decrease) for fiscal 2022 was $0.00.
- Bausch Health Companies Inc. goodwill, other increase (decrease) for fiscal 2021 was $0.00.
- Bausch Health Companies Inc. goodwill, other increase (decrease) for fiscal 2016 was $0.00.
| Period end | Goodwill, Other Increase (Decrease) | Goodwill, Other Increase (Decrease) 3 month | Goodwill, Other Increase (Decrease) 6 month | Goodwill, Other Increase (Decrease) 9 month | Goodwill, Other Increase (Decrease) 12 month |
|---|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $0.00 derived: sum of 2 quarters · filed 2024-02-22 | $0.00 derived: sum of 3 quarters · filed 2024-02-22 | $0.00 10-K · filed 2024-02-22 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | $0.00 derived: sum of 4 quarters · filed 2023-02-23 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $0.00 10-Q · filed 2022-08-09 | $0.00 derived: sum of 3 quarters · filed 2023-02-23 | $0.00 derived: sum of 4 quarters · filed 2023-02-23 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 | $0.00 derived: sum of 2 quarters · filed 2023-02-23 | $0.00 derived: sum of 3 quarters · filed 2023-02-23 | $0.00 derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $0.00 derived: sum of 2 quarters · filed 2023-02-23 | $0.00 derived: sum of 3 quarters · filed 2023-02-23 | $0.00 10-K · filed 2023-02-23 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $0.00 derived: sum of 2 quarters · filed 2021-11-02 | $0.00 10-Q · filed 2021-11-02 | ||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $0.00 10-Q · filed 2021-08-03 | |||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-04 | ||||
| 2017-01-01 | $0.00 10-K · filed 2020-02-19 | ||||
| 2016-12-31 | $0.00 10-K · filed 2019-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |